Ipamorelin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Ipamorelin (Ipamorelin) is researched primarily for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support. The most selective GH secretagogue available — the only GHRP that doesn't meaningfully raise cortisol, prolactin, or appetite at therapeutic doses, making it the safest entry point for GH optimization. It belongs to the Growth Hormone Secretagogue (GHS) / Ghrelin mimetic category of compounds.
What Is Ipamorelin?
Ipamorelin (Ipamorelin) is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic. Synthetic pentapeptide derived from GHRP-1, engineered for selective GH release.
The most selective GH secretagogue available — the only GHRP that doesn't meaningfully raise cortisol, prolactin, or appetite at therapeutic doses, making it the safest entry point for GH optimization. It has attracted significant research interest for its potential effects on growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.
How Does Ipamorelin Produce These Benefits?
Ipamorelin selectively stimulates GH release by mimicking ghrelin at the GHS-R receptor on pituitary somatotrophs. Unlike other GHRPs (GHRP-2, GHRP-6, Hexarelin), it does not significantly increase cortisol, prolactin, or ACTH at therapeutic doses — making it the cleanest GH secretagogue available with the fewest hormonal side effects.
This multi-pathway activity is why Ipamorelin shows potential across several different applications rather than being limited to a single use case.
Can Ipamorelin Help With Growth Hormone Release?
Research suggests Ipamorelin may support growth hormone release through its growth hormone secretagogue (ghs) / ghrelin mimetic activity. Phase II clinical trials confirm selective GH release without significant effects on cortisol or prolactin. Demonstrated the most favorable side-effect profile of any growth hormone secretagogue in direct comparisons.
Protocols targeting growth hormone release typically use 200-300 mcg administered 2-3 times daily for 8-12 weeks, often stacked with CJC-1295.
Can Ipamorelin Help With Improved Sleep?
Research suggests Ipamorelin may support improved sleep through its growth hormone secretagogue (ghs) / ghrelin mimetic activity. Phase II clinical trials confirm selective GH release without significant effects on cortisol or prolactin. Demonstrated the most favorable side-effect profile of any growth hormone secretagogue in direct comparisons.
Protocols targeting improved sleep typically use 200-300 mcg administered 2-3 times daily for 8-12 weeks, often stacked with CJC-1295.
Can Ipamorelin Help With Fat Loss?
Research suggests Ipamorelin may support fat loss through its growth hormone secretagogue (ghs) / ghrelin mimetic activity. Phase II clinical trials confirm selective GH release without significant effects on cortisol or prolactin. Demonstrated the most favorable side-effect profile of any growth hormone secretagogue in direct comparisons.
Protocols targeting fat loss typically use 200-300 mcg administered 2-3 times daily for 8-12 weeks, often stacked with CJC-1295.
Can Ipamorelin Help With Muscle Recovery?
Research suggests Ipamorelin may support muscle recovery through its growth hormone secretagogue (ghs) / ghrelin mimetic activity. Phase II clinical trials confirm selective GH release without significant effects on cortisol or prolactin. Demonstrated the most favorable side-effect profile of any growth hormone secretagogue in direct comparisons.
Protocols targeting muscle recovery typically use 200-300 mcg administered 2-3 times daily for 8-12 weeks, often stacked with CJC-1295.
Can Ipamorelin Help With Bone Density Support?
Research suggests Ipamorelin may support bone density support through its growth hormone secretagogue (ghs) / ghrelin mimetic activity. Phase II clinical trials confirm selective GH release without significant effects on cortisol or prolactin. Demonstrated the most favorable side-effect profile of any growth hormone secretagogue in direct comparisons.
Protocols targeting bone density support typically use 200-300 mcg administered 2-3 times daily for 8-12 weeks, often stacked with CJC-1295.
Can Stacking Enhance Ipamorelin Benefits?
Best paired with CJC-1295 no DAC for synergistic GH release — the GHRH + GHRP combination amplifies GH pulse amplitude beyond what either achieves alone. This is the most widely recommended beginner GH peptide stack.
See our Ipamorelin stacking guide for detailed combination protocols.
What Is the Bottom Line on Ipamorelin Benefits?
Ipamorelin is researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support. The evidence base includes: Phase II clinical trials confirm selective GH release without significant effects on cortisol or prolactin. Demonstrated the most favorable side-effect profile of any growth hormone secretagogue in direct comparisons.
Ipamorelin is not fda-approved. research chemical. banned by wada. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
Ipamorelin: The Cleanest GH Secretagogue
Related Reading
- Ipamorelin Dosage Guide
- Ipamorelin Side Effects
- Ipamorelin Stacking Guide
- Ipamorelin Cycle Guide
- Ipamorelin Research
- CJC-1295 Complete Guide
Calculate Your Ipamorelin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Ipamorelin.
Open Calculator →Research-Grade Sourcing
If you're going to research Ipamorelin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin (Ipamorelin) is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic. Synthetic pentapeptide derived from GHRP-1, engineered for selective GH release. It is researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.
What is the recommended Ipamorelin dosage?
Common dosages: 200-300 mcg administered 2-3 times daily via subcutaneous injection. Cycle length: 8-12 weeks, often stacked with CJC-1295. Half-life: approximately 2 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of Ipamorelin?
Minimal side effects compared to other GH secretagogues. Mild headache, light-headedness, or injection site reactions possible. Does not cause the intense hunger seen with GHRP-6 or the cortisol/prolactin spikes seen with GHRP-2.
Is Ipamorelin safe?
Ipamorelin has shown a preliminary safety profile in research. Not FDA-approved. Research chemical. Banned by WADA. All research should follow appropriate safety protocols.